GlassScriptPhysician profile
Dylan J Rodner
NPI 1669599882
$1,097.56
in general payments reported to CMS, 2019-2025
20 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $83.56 · 2024: $546 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $314.98 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $138.21 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $69.13 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $68.40 | 2023-2025 | Airsupra, Farxiga |
| Amgen INC. | $64.02 | 2023-2024 | Evenity, Prolia, Otezla |
| Pfizer INC. | $59.35 | 2024-2025 | |
| Axsome Therapeutics, INC. | $41.50 | 2025 | Auvelity |
| Abbvie INC. | $39.44 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.08 | 2024 | Jardiance, Tradjenta, Synjardy |
| Exact Sciences Corporation | $33.50 | 2024-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $32.66 | 2025 | Korlym |
| Madrigal Pharmaceuticals | $32.13 | 2025 | Rezdiffra |
| Kyowa Kirin, INC. | $27.15 | 2025 | |
| Seqirus USA INC | $24.03 | 2025 | Flucelvax, Fluad |
| Merck Sharp & Dohme LLC | $23.66 | 2025 | Lagevrio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.97 | 2024 | |
| Beta Bionics, INC. | $20.01 | 2024 | Ilet Bionic Pancreas |
| Dexcom, INC. | $20.00 | 2024 | Dexcom G6 Transmitter |
| Cequr Corporation | $15.99 | 2024 | Cequr Simplicity |
| Tolmar, INC. | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Rodner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.